The reduction in price target from $229 to $201 by Barclays suggests a less optimistic view on CDW's future performance, which could lead to a negative short-term impact on the stock price. The Equal-Weight rating indicates a neutral stance, but the lowered target reflects potential challenges or lower growth expectations.